Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GDP Chemotherapy in Peripheral T-cell Lymphoma
NCT02404571Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jan 2011
- Primary completion
- Dec 2016
- Modality
- Nanoparticles, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, Cisplatin micelle injection (HA132), dexamethasone in peripheral T-cell lymphoma (PTCL), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)dexamethasone
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT02404571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02404571.